Assesment of Treatment Outcomes of Aquired Aplastic Anemia in Children : A Retrospective and Prospective Cohort
NCT07131878 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2025-08-20
Summary
The goal of this observational study is to to assess of treatment Outcomes of Aquired Aplastic Anemia in children
Conditions
- Aplastic Anaemia (AA)
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-15
- Primary Completion
- 2027-09-15
- Completion
- 2028-01-15
More Related Trials
-
Treatment of Iron Deficiency Anaemia in Pregnancy Study
NCT03725150 ·Status: COMPLETED
-
Thrombophilia In Beta Thalassemia
NCT04219449 ·Status: NOT_YET_RECRUITING
-
An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old
NCT01724138 ·Status: WITHDRAWN ·Phase: PHASE4
-
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
NCT00736060 ·Status: COMPLETED
-
Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
NCT06071377 ·Status: RECRUITING
-
Spectrum of Hematological Disorders in Pediatrics
NCT05473650 ·Status: UNKNOWN
-
N-Acetylcysteine in Patients With Sickle Cell Disease
NCT01849016 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
Clinical Experience of Thalidomide in Thalassemic Patients
NCT05132270 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome
NCT01310959 ·Status: UNKNOWN
-
Multi Center Case Control Study on Multiple Risk Factors of Aplastic Anemia
NCT03208647 ·Status: COMPLETED
-
Second-line Treatment of Primary Autoimmune Hemolytic Anemia
NCT05057468 ·Status: RECRUITING ·Phase: PHASE3
-
Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic Anemia
NCT06743854 ·Status: NOT_YET_RECRUITING
-
Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease
NCT05861453 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia
NCT03271541 ·Status: COMPLETED ·Phase: PHASE2
-
HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease
NCT03240731 ·Status: COMPLETED ·Phase: PHASE2
-
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
NCT02173951 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients
NCT06708728 ·Status: NOT_YET_RECRUITING
-
A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia
NCT06678165 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Iron Therapy in Erythropoietic Protoporphyria
NCT05572125 ·Status: COMPLETED
-
Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants
NCT03359447 ·Status: UNKNOWN ·Phase: PHASE4
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital
NCT03273998 ·Status: UNKNOWN
-
Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia
NCT07340450 ·Status: COMPLETED ·Phase: NA
-
Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia
NCT01461590 ·Status: COMPLETED ·Phase: PHASE2